FutureBridge invites you to their event

Disruptive Innovations Shaping the Future of Adoptive Cell Therapies

About this event

The therapeutic potential of cell therapies is an established fact, but whether will they be able to overcome challenges posed by Solid Tumors remains a question. With innovative strategies, many types of cell therapies are being developed by Industry and academia with a focus on succeeding in Solid tumors. Engineered receptors (like CAR/ TCR), novel gene-editing techniques (CRISPR/ Transposons/ lentiviral, etc), scaling processes, etc are being developed to actualize the dream of transforming patients' treatment through cell therapies.

Let's explore the upcoming disruptive innovations that will bring about a paradigm shift in the development and success of cell therapies in solid tumors.

FutureBridge’s Oncology Analysts in this webinar will cover:

  • Residual unmet needs that are unlikely to be answered by upcoming platforms
  • The focus of current innovations on improving cell therapies
  • What innovation trend is driving the technological reform in cell therapies?
  • Reproducible quick manufacturing and scaling platforms of cell therapies
  • Innovative platforms that hold the potential to push cell therapy toward success in Solid Tumors
  • FutureBridge's vision and take on industry transformation

Hosted by

  • Team member
    T
    Sandhya Nambiar Research Specialist @ FutureBridge

    I am a Life science specialist with a PhD in clinical Biochemistry and hold a keen interest and passion for immuno-oncology. Associated to FutureBridge (oncology consulting) for providing on-demand and strategic insights on new evolving scientific technologies and innovations.

  • Team member
    T
    Ankita Malik Consultant @ FutureBridge

    A molecular biologist with expertise in oncology business research and consulting, R&D strategy, and competitive and treatment landscapes for companies developing oncology assets.

  • Team member
    T
    Nidhi Dhingra Director, Oncology @ FutureBridge

    I am life sciences professional with ~20 years overall experience in drug discovery, pharma, oncology/immuno-oncology consulting. I provide consultation to global clients to support their strategic business decisions.

FutureBridge

Be the Future.

FutureBridge is a techno-commercial consulting and advisory company.

We track and advise on the future of industries from a 1-to-25-year perspective to keep you ahead of the technology curve, propel your growth, Identify new opportunities, markets and business models, answer your unknowns, and fac